Location History:
- Woodside, CA (US) (2007)
- La Honda, CA (US) (2008)
- Foster City, CA (US) (2015 - 2024)
Company Filing History:
5 out of 114 
4 out of 52 
1 out of 832,843 Years Active: 2007-2025
Introduction
Gerald J Wallweber, based in Foster City, CA, has made significant contributions to the field of medical innovation, particularly in cancer research. With a remarkable portfolio of 9 patents, Wallweber is recognized for his groundbreaking work in predicting the survival likelihood and metastasis in cancer patients.
Latest Patents
Among his latest patents, Wallweber developed methods for determining the likelihood of survival and predicting the likelihood of metastasis in cancer patients. This invention focuses on accurately quantifying HER2 and/or p95 expression in subjects with HER2 positive cancer, shedding light on the risk of brain relapse for these patients. His innovative approaches are aimed at improving diagnostic accuracy and patient outcomes in oncology.
Career Highlights
Throughout his career, Gerald has collaborated with prominent organizations such as Monogram Biosciences, Inc. and Laboratory Corporation of America Holdings. His work in these institutions has cemented his role as a key player in advancing cancer diagnostics and therapeutics.
Collaborations
Working alongside talented professionals like Sharat Singh and Hossein Salimi-Moosavi, Wallweber has contributed to a wealth of knowledge and innovation in the medical field. These collaborations have paved the way for new techniques and methodologies that enhance understanding of cancer biology.
Conclusion
Gerald J Wallweber’s dedication to cancer research and his innovative inventions have positioned him as a notable inventor in the medical industry. His methods for assessing cancer prognostics showcase the vital link between innovation and improved healthcare solutions.